| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 09/26/2007 | CN101040988A Chinese prepared medicine compound for treating and preventing gynecologic endocrine disorders |
| 09/26/2007 | CN101040710A Health-care nutritious medicinal granules which can be took orally for controlling the incretion for women and can also be used on the skin for beauty |
| 09/26/2007 | CN100339374C Compounds and methods for modulation of estrogen receptors |
| 09/25/2007 | USRE39862 Unsaturated 14, 15-cyclopropanoandrostanes, a method for their production and pharmaceutical compositions containing these compounds |
| 09/25/2007 | CA2054686C Treatment of polycystic ovarian disease |
| 09/20/2007 | WO2007104196A1 Lhrh antagonist possessing low histamine releasing effect |
| 09/20/2007 | WO2007087518A3 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
| 09/20/2007 | WO2007056500A3 Compounds with activity at estrogen receptors |
| 09/20/2007 | US20070219232 Chemical Compounds |
| 09/20/2007 | US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both |
| 09/20/2007 | US20070218059 Cell Surface Marker |
| 09/19/2007 | EP1834644A2 Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases |
| 09/19/2007 | EP1834639A1 Remedial agent for fat toxicity |
| 09/19/2007 | EP1833494A2 Regeneration of pancreatic islets by amniotic fluid stem cell therapy |
| 09/19/2007 | EP1490335B1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 09/19/2007 | EP1439841B1 Androgen receptor modulators and methods of use thereof |
| 09/19/2007 | CN101036660A Estrogen gelatin medicine and the method for preparing the same |
| 09/19/2007 | CN101036621A Foaming composition |
| 09/19/2007 | CN101036492A Chinese holly tea |
| 09/19/2007 | CN100338219C Tissue specific expression of retinoblastoma protein |
| 09/18/2007 | USRE39847 Method of treating a systemic disease |
| 09/18/2007 | US7271188 e.g. 4-[3'-(3''-aminosulfonylpropyl)-4',4'-dimethyl-5'-oxo-2'-thioxo-1'-imidazolidinyl]-2-trifluoromethylbenzonitrile; anti-androgen agent which has a sufficient antagonistic effect and reduced side effect profile |
| 09/18/2007 | US7271175 Androgen sensitive diseases; prostate cancer; skin disorders; alopecia |
| 09/18/2007 | CA2414680C Methods for treating inflammation-mediated conditions of the eye |
| 09/18/2007 | CA2392473C Bioadhesive drug delivery system |
| 09/18/2007 | CA2338859C Estradiol-containing patch for transdermal administration of hormones |
| 09/18/2007 | CA2032859C Method of reducing or preventing adverse effect of steroid therapy and compositions therefor |
| 09/13/2007 | WO2007103282A2 Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production |
| 09/13/2007 | US20070212714 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof |
| 09/13/2007 | US20070212325 Insulin Resistance-Improving Agent |
| 09/13/2007 | CA2644468A1 Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production |
| 09/12/2007 | EP1832599A2 Albumin fusion proteins |
| 09/12/2007 | EP1832590A2 Tri- heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 09/12/2007 | EP1831240A1 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same |
| 09/12/2007 | EP1830806A2 Sustained release formulation comprising bisphosphonate |
| 09/12/2007 | EP1395566B1 Tricyclic compounds useful as angiotensin ii agonists |
| 09/12/2007 | EP1154788B9 Method for indentifying compounds that modulate sister chromatid separation |
| 09/12/2007 | CN101032552A Curing purpose of total flavonoids from mulberry tree leaf |
| 09/12/2007 | CN101032483A Composing of hydantoin ramification for adjusting estrogen receptor activity and application thereof |
| 09/11/2007 | US7268213 Glucagon-like peptide-1 (glp-1) receptor agonist |
| 09/11/2007 | US7268152 Antiinflammatory agents; antiallergens; antiproliferative agents |
| 09/11/2007 | US7268149 Cyclothiocarbamate derivatives as progesterone receptor modulators and methods of treating skin disorders |
| 09/11/2007 | US7268146 (3,4-Dihydro-1H-isoquinolin-2-yl)-[2-methyl-7-(2,4,6-trimethyl-phenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]pyridin-3-yl]-methanone; Corticotropin releasing factor (CRF); stress-related illnesses, mood disorders such as depression, major depressive disorder, single episode depression |
| 09/11/2007 | US7268113 Administering dosage complexed to blood |
| 09/11/2007 | US7267813 Inhalation particles incorporating a combination of two or more active ingredients |
| 09/11/2007 | CA2372720C Androgen glycosides and androgenic activity thereof |
| 09/07/2007 | WO2007100066A1 17β HSD type 5 INHIBITOR |
| 09/07/2007 | WO2007099200A1 Selective androgen receptor modulators |
| 09/07/2007 | CA2644809A1 17 .beta. hsd type 5 inhibitor |
| 09/07/2007 | CA2642598A1 Selective androgen receptor modulators |
| 09/06/2007 | US20070208179 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 09/06/2007 | US20070208066 ER-beta-selective ligands |
| 09/06/2007 | US20070208049 e.g. 1-(2,6-Difluorobenzyl)-5-(3-Mehthoxyphenyl)-6-Methyl-3-[N-Methyl -N -(2-Pyridylethyl)Aminoethyl]Uracil; anticarcinoganic agent; prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 09/06/2007 | US20070208046 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders |
| 09/06/2007 | US20070207134 Functional food for ameliorating engogenous melatonin secretion rhythm and functional food for ameliorating circadian rhythm |
| 09/05/2007 | EP1830191A2 Pharmaceutical preparations containing thiazolidinediones showing new therapeutic indications |
| 09/05/2007 | EP1829876A1 Nitrogeneous tricyclic compound |
| 09/05/2007 | EP1829529A1 Controlled release compositions of estradiol metabolites |
| 09/05/2007 | EP1828248A2 Compositions comprising anti-igf-1 receptor antibodies and methods for obtaining said antibodies |
| 09/05/2007 | EP1828098A1 Crystal forms of cinacalcet hci and processes for their preparation |
| 09/05/2007 | EP1441724B1 Methods of increasing endogenous testosterone levels |
| 09/05/2007 | CN101029080A Methods and compositions for derepression of IAP-inhibited caspase |
| 09/05/2007 | CN101029042A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 09/05/2007 | CN101028440A Oral Chinese-medicinal composition for treating hyperthyroidism |
| 09/05/2007 | CN101028407A Oral Chinese-medicinal composition for treating hyperthyroidism |
| 09/05/2007 | CN101028311A Use of selaginella tamariscina |
| 09/04/2007 | US7265227 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 09/04/2007 | US7265157 Sustained release compositions, process for producing the same and use thereof |
| 09/04/2007 | US7265156 Medicinal association of a biguanine and a carrier, for example metformin and arginine |
| 09/04/2007 | US7265154 Valproic acid and derivatives thereof as histone deacetylase inhibitors |
| 09/04/2007 | US7265137 Phenylacetic acid derivative; hypoglycemic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders |
| 09/04/2007 | US7265119 For therapy of nicotine dependency |
| 09/04/2007 | US7264798 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus |
| 08/30/2007 | WO2007097289A1 Novel pharmaceutical |
| 08/30/2007 | WO2007095737A1 Combination therapy for the treatment of diabetes comprising an exendin agonist and a gastrin compound |
| 08/30/2007 | WO2007050726A3 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists |
| 08/30/2007 | WO2007008474A3 3 -ester prodrugs of estradiol |
| 08/30/2007 | US20070203198 Pioglitazone insulin sensitivity enhancer with the antidiabetic glimepiride; difference in mechanism of action avoids adverse reactions over long term use; oral dosage tablet; lactose excipient, hydroxypropylcellulose binder, magnesium stearate lubricant, calcium carbonate disintegrator; diabetes |
| 08/30/2007 | US20070203184 Novel Indolin-2-one Derivatives, Their Preparation and the Pharmaceutical Compositions Comprising Them |
| 08/30/2007 | US20070202099 Antibody Drug |
| 08/30/2007 | CA2642834A1 Oxa-steroids derivatives as selective progesterone receptor modulators |
| 08/30/2007 | CA2642829A1 11-phosphorous steroid derivatives useful as progesterone receptor modulators |
| 08/30/2007 | CA2642566A1 17-phosphorous steroid derivatives useful as progesterone receptor modulators |
| 08/29/2007 | EP1826216A1 Glp-1 derivatives |
| 08/29/2007 | EP1824863A1 Silicon compounds and their use |
| 08/29/2007 | EP1824862A1 Silicon compounds and their use |
| 08/29/2007 | EP1824478A2 Novel uses for estrogen beta agonists |
| 08/29/2007 | EP1746993A4 Controlled release metformin compositions |
| 08/29/2007 | EP1644385B1 Silicon compounds and their use |
| 08/29/2007 | EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor |
| 08/29/2007 | EP1333840B9 M. tuberculosis chaperonin 60.1 and uses thereof |
| 08/29/2007 | CN101024622A Theanine amino-acid salt, its preparing method and use |
| 08/29/2007 | CN101023935A Method for preparing insulin capsule |
| 08/29/2007 | CN100334109C GLP-1 analogues |
| 08/29/2007 | CN100334077C Benzimidazole derivatives and their use as GNRH antagonists |
| 08/28/2007 | US7262297 For lowering blood glucose |
| 08/28/2007 | CA2222103C Inositolglycans having insulin-like action |
| 08/23/2007 | WO2007095423A1 Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators |
| 08/23/2007 | WO2007093366A1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 08/23/2007 | WO2007075884A3 Androgen receptor modulator compounds and methods |